ASO Author Reflections: Unlocking the Potential of Noncoding RNAs in Gastric Cancer: From Molecular Insights to Precision Treatment.
Gastric cancer (GC) presents a major health challenge owing to its late diagnosis, molecular complexity, and resistance to therapies.
APA
Gu C, ChenLiu Z, et al. (2025). ASO Author Reflections: Unlocking the Potential of Noncoding RNAs in Gastric Cancer: From Molecular Insights to Precision Treatment.. Annals of surgical oncology, 32(8), 6104-6105. https://doi.org/10.1245/s10434-025-17455-x
MLA
Gu C, et al.. "ASO Author Reflections: Unlocking the Potential of Noncoding RNAs in Gastric Cancer: From Molecular Insights to Precision Treatment.." Annals of surgical oncology, vol. 32, no. 8, 2025, pp. 6104-6105.
PMID
40483315
Abstract
Gastric cancer (GC) presents a major health challenge owing to its late diagnosis, molecular complexity, and resistance to therapies. In this work, noncoding RNAs (ncRNAs), such as miRNAs, lncRNAs, and circRNAs, are identified as critical factors in GC progression and treatment resistance. These findings highlight the potential of ncRNAs in advancing diagnostic strategies and developing novel therapeutic approaches. However, challenges in optimizing delivery methods and validating clinical effectiveness remain. Future efforts should focus on integrating ncRNA insights into precision medicine and addressing these clinical barriers to improve patient outcomes in GC.
MeSH Terms
Humans; Stomach Neoplasms; Precision Medicine; RNA, Untranslated; Biomarkers, Tumor; Prognosis; Gene Expression Regulation, Neoplastic
같은 제1저자의 인용 많은 논문 (5)
- A lung microbial signature for postoperative recurrence in stage I-II non-small cell lung cancer.
- Nintedanib Is a Potent FLT3 Inhibitor with Activity Against FLT3-ITD and Overcomes the Gatekeeper F691L Resistance Mutation in Acute Myeloid Leukemia.
- Amino acid metabolism related gene signatures for predicting prognosis and immune infiltration in gastric cancer.
- An innovative engineered IL-10 monomer strengthens T cell-mediated anti-tumor responses through anti-PD-1 cis-delivery.
- Thyroid peroxidase antibodies do not impair the ovarian reserve in euthyroid women: a cross-sectional study.